An interventional study of Application of an action protocol for the management of delirium through the use of non-pharmacological interventions and Tradicional management of delirium in Delirium Treatment, Delirium Confusional State and Delirium in Old Age, sponsored by Universitat de Lleida. Not yet recruiting at 1 site in Spain. Open to participants aged 80 Years to 130 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-29.
Sponsored by Universitat de Lleida · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 16 studies in Delirium with a site in Spain — 4 open to participants now, 4 under way, none of them phase 3. Delirium · Spain.
Among the 16 studies in Delirium with a site in Spain, this one is the 9th largest by planned enrollment of the 13 interventional ones that give a count, is one of 2 that started in 2026, is one of 9 with no phase, and was the 12th registered.
935 studies on the registry are indexed under Delirium; 188 are open to participants now.
Browse Delirium studies →4 of the 16 studies in Delirium with a site in Spain are open now. Recruiting first, the newest first:
Institut Investigacio Sanitaria Pere Virgili · Sites in Spain
Ages 60+ · Healthy volunteers
Instituto de Investigación Hospital Universitario La Paz · Sites in Spain
Ages 18–80
Cardenal Herrera University · Sites in Spain
Ages 65+
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 124 Delirium studies recruiting now, 96 (77%) set no upper age limit and 8 (6%) stop at 75 or younger; 8 take children under 18; 14 take healthy volunteers.
This study: 80 Years to 130 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 2 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 65 is below the median of 111 across 551 interventional studies indexed under Delirium.
Median enrollment 105 across the 13 interventional studies, 506 across the 3 observational. Of the 9 that completed or were terminated, 1 (11%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 16 have an industry lead sponsor. The 10 most frequent:
Universitat de Lleida is the lead sponsor of 33 studies on the registry; 19 are open to participants now.
Universitat de Lleida has 1 study filed under Delirium — fewer than ten, so there is no comparison to draw.
2 of the studies in Delirium with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07000526Instituto de Investigación Hospital Universitario La PazInhaled Sedation in Critically Ill Patients | 2027-03 |
| NCT06809894Universitat de LleidaManagement of Non-pharmacologic Delirium With the Use of a Nursing-led E-health Project: a Randonmized Controlled Trial | 2027-06-01 |
Add all 2 to your calendar (.ics) → With an account.
Among the 16 studies in Delirium with a site in Spain, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Application of an action protocol focused on the application of non-pharmacological interventions for managing delirium in the process of prevention, diagnosis and treatment, evaluated using an e-health intervention, with a tablet to introduce on it the data about the prevention, diagnostic and treatment process of each recluted patient, in the Igualada Hospital Center, once a day.
Generalities Delirium, also known as acute confusional syndrome (ACS), is one of the most common complications in hospitalized patients because its underdiagnosed, increased dependence on basic activities of daily living (ADLs), morbidity and mortality, with nearly 23 deaths per 100 patients diagnosed with delirium. It affects up to 40% of patients over 65 years of age.
Its occurrence is more frequent in specific hospital settings, such as intensive care units (ICU), emergency departments, or units treating respiratory conditions.
Several risk factors contribute to the development of delirium, including age (patients over 65 are at higher risk), gender (it is more common in men), polypharmacy, and invasive procedures like bladder catheterization. Patients with urinary tract infections (UTIs) or strictures also face an increased risk.
In addition, comorbidities like diabetes, stroke, heart failure, or COPD increases the risk of tdeveloping delirium.
The duration of delirium symptoms can be hours to days, in the 80% of cases, and 20% lasting weeks or even months (4).
To minimize its impact, it's crucial to focus on proper prevention, early detection, and effective management. A non-pharmacological approach to treatment is key, as reducing medication use can help prevent adverse effects that may worsen the patient's condition.
Provide adequate training and education for healthcare professionals is essential. To reduce the incidence of delirium in hospitalized patients, a protocol has been developed for its prevention, detection, and treatment through non-pharmacological interventions.
Aims General aim To reduce the incidence of delirium through the management of non-pharmacological therapy in the geriatric unit of professionals at the University Hospital of Igualada in the prevention, diagnosis and treatment of hospitalized elderly patients, using a nursing-led e-health intervention.
2.1. Specific aims To determine whether there are differences in the incidence of delirium with the application of an e-health tablet program, comparing ta control group to and intervention group.
Scope of application The application of the protocol is aimed at the University Hospital of Igualada, at the internal medicine units, with the possibility of extrapolating to other units or health centers.
The protocol is aimed at nurses in the geriatric unit and may receive help from other professionals such as rehabilitation, cleaning, or medical staff in collaborating in the development of the activities.
Population and sample The population will include the total number of patients admitted to geriatric unit.
The patient sample will consist of those who have at least three risk factor for developing delirium, such as age (over 80 years old), gender (male), or benzodiazepines treatment.
The total sample size will be 65 patients, 32 in the control group and 33 in the intervention group, calculated using the QuestionPro website, based on a population of 77 diagnosed delirium cases in the study units over a 6-month period in 2024 (information provided by the HUI research team). This tool has a margin of error of 5% and a confidence level of 95%.
The intervention will be carried out by the IP, who is the owner of the development of the e-health application.
4.1. Inclusion/exclusion criteria Inclusion criteria: Age over 80 years, 3 or more risk factors, admission on geriatric unit in Igualada Hospital Center and social support during the hospital admission.
Exclusion criteria: Age under 80 years, not presence of risk factors or less than 3, delirium diagnosis in their admission or earlier and foreseeable death on admission not caused by delirium.
The data collection will be carried out by the IP once a day, in the morning, during 3 days for each patient of the intervention group.
The data entered into these forms will be automatically transferred into an Excel document with their download in the app. This document will be downloaded by the center's IT team at 3 months after the protocol is implemented, for further analysis.
The Excel document will display the results from each intervention and scale's results, categorized into the following items for further evaluation of the indicators:
Below are the indicators that will be used for the analysis of the data:
INDICATOR 1 Indicator: Rate of patients at risk of developing delirium Zone: Geriatric unit Quality criteria Any patient, on the control or intervention group, presenting symptomatology equivalent to delirium must be assigned this diagnosis.
Definitions: The CAM scale is the reference scale for making the diagnosis of delirium in patients, assessing affirmative answers in 3 or 4 of its items.
Justifications: The diagnosis is made using the CAM scale, assessed once there is a suspicion of the diagnosis, which serves as an element in the diagnosis of the disease. It is recorded using the center's computer program.
Target population: Hospitalized patients over 80 years of age with 3 or more risk factors for the development of delirium.
Formula: Numerator: No. of patients with delirium* 100 / Denominator: Total number of assessed risk patients Type of indicator: Result Data source: Registered in e-health tablet program. Responsible: IP
Periodicity:
INDICATOR 2 Indicator: Rate of patients diagnosed with delirium who improve their clinical severity Zone: Geriatric unit Quality criteria: All patients, in the control or intervention group, diagnosed with delirium, must be treated and their symptomatology reduced, assessing the severity of the symptoms.
Definitions: The DRS-R-98 scale assesses the severity of clinical delirium with the evaluation of 7 items, rated from 0 to 4. A higher score indicates more severity, up to 48 points.
Justification: Through DRS-R-98, the severity of the clinical condition is assessed and whether it improves with the application of non-pharmacological therapy. Recorded in the center's computer program, every 24 hours.
Any score equal to or less than 16 will be considered a favorable score, and therefore, a seriousness of the clinic. On the contrary, scores equal to or higher than 17 points, up to a maximum of 48, will indicate a serious severity.
Target population: Hospitalized patients over 80 years old diagnosed with delirium.
Formula: Numerator: No. of patients with a score of less than 16 on the DRS-R-98 scale * 100 / Denominator: No. of patients diagnosed with delirium Type of indicator: Process Data source: Registered on SAVAC program. Responsible: IP
Periodicity:
INDICATOR 3 Indicator: Rate of drug use in the treatment of delirium Zone: Geriatric unit Quality: All patients, in the control or intervention group, diagnosed with delirium and treated must be able to reduce their hospital stay.
Definitions: Patients diagnosed with delirium tend to have longer hospital stays due to this diagnosis if they are not treated.
Justification: It is assessed on the basis of the number of days spent in hospital, recorded in the patient's clinical history.
Target population: Hospitalized patients over 80 years old diagnosed with delirium.
Formula: Numerator: No. of days with a diagnosis of delirium* 10 / Denominator: Total number of hospitalized days Type of indicator: Result Data source. Clinical history Responsible: IP Periodicity: Quarterly
5.1. Prevention
Prevention will be applied to all patients who are admitted to the units where the protocol is applied and present at least 3 risk factor for the development of delirium. As risk factors, they will be considered (2):
An other precipitant factors:
The activities classified with the level of evidence (number) and the degreee of evidence (letter) are:
Cognitive Stimulation
Early Mobilization
Optimal Hydration and Nutrition
Maintenance of the Sleep-Wake Cycle
Promotion of Spatial and Temporal Orientation
5.2. Diagnosis The diagnostic starts when a patient have kind of symptomatology that may trigger delirium.
The nurses cannot assign any type of diagnosis to a patient, but they do have at our disposal tools that facilitate this detection and, together with the medical staff, can determine whether the patient has a diagnosis of delirium.
To make the diagnosis, the Confusional Assessment Method (CAM) and Delirium Rating Scale-Revision-98 (DRS-R-98) will be used to assess the symptomatology and severity of the symptoms.
The following is a summary of what characterizes each scale:
These will be completed in the e-heakth program for the IP , where these scales will be included in the patient's registration form.
Once completed, and depending on the results obtained, it will be decided whether the patient is a candidate for a diagnosis of delirium, the respective doctor will be notified, and therefore, specific activities for the treatment of symptomatology will be implemented in the patient's care.
5.3. Treatment's intervention Action on the symptoms will be carried out once the patient has been diagnosed with delirium. The activities to be carried out are similar to those developed in the prevention phase, but more focused on improving the patient's cognitive status.
They will be conducted, once again, bby IP, without leaving aside other professionals such as rehabilitation, physiotherapy or doctors who may collaborate in their development.
The activities classified with the level of evidence (number) and the degreee of evidence (letter) are:
Cognitive Stimulation
In the case of Covid-19, daily video calls at a set time. Talk to the nursing team and the family to arrange visiting hours or video calls, preferably before bedtime, as this is when the patient is most alert, especially after dinner, to ensure the patient gets a good night's rest.
This should be done during hygiene routines or when food is served, both by nurses and nursing assistants.
Physical Exercises
Encourage physiotherapy.
Encourage physiotherapy.
Orientation Management
Take advantage of moments when injuries are being treated or medication is being administered, especially by nurses.
(1, A) Let the patient know the time and day whenever possible when entering the room.
d. Music Therapy
5.4. Assessment of symptoms The assessment of symptoms will be carried out by the nursing staff every 48 hours after the diagnosis of delirium until the patient is discharged from the unit.
This will be the last phase of the application of the protocol, assessing the fluctuation of symptomatology and the effectiveness of the activities conducted.
This phase will be completed with the new completion of the DRS-R-98 scale in the program, as soon as the tasks in the infirmary are completed.
The results of the data, as well as the indicators and subsequent evaluation of the impact of the protocol, will be carried out by the hospital supervisor.
935 studies on the registry are indexed under Delirium; 188 are open to participants now.
This study's planned enrollment of 65 is below the median of 111 across 551 interventional studies indexed under Delirium.
Browse Delirium studies →Universitat de Lleida is the lead sponsor of 33 studies on the registry; 19 are open to participants now.
Compared within Delirium, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Confusion. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion criteria:
A quantitative study is carried out in which the indices described in the description of the study are studied in order to assess the effectiveness of the implementation of delirium.
Procedure: Application of an action protocol for the management of delirium through the use of non-pharmacological interventions
The use of traditional ways to manage the delirium in hosoitalized older patient, based especially in the use of pharmacological interventions and mechanical patient restraint were compared with the new interventions includes in the new protocol to valorate the effectiveness of the new way to management delirium based in non-pharmacological interventions.
Other: Tradicional management of delirium
The interventions carried out stand out for being non-pharmacological, this avoiding the use of drugs and polypharmacy in elderly patients, avoiding the appearance of clinical complications derived from the side effects that the use of these substances can lead to in the patient. In addition, it also encourages the education of health professionals and nurses' families or caregivers in the management of delirium.
Also known as: orientation, mobilitzation, education, feeding assistance, Hypoxemia, Pain, fluid repletion, Therapeutic activities, Nursing Assessment and Intervention Interdisciplinar, Sleep enhancement, Vision and hearing adaptation
The use of the pharmacological treatment and the mechanical patients restrain were de base of the traditional treatment in deliriums patient in the University hospital of Igualada, because of the less knowledge of the professionals and non-existence protocol of non-pharmacological interventions to management the delirium.
Also known as: pharmacology, mechanical restrain
Rate of patients who develop delirium
It is performed on all patients admitted to geriatric unit with 3 or more risk criteria for the development of delirium. Its measurement is carried out in the morning shift using the Confussional Assesment Scale scale. The score is from 0 to 4 points, with a positive diagnosis being one with a score greater than 2. It compares the incidence of the control group and the intervention group.
Time frame: Its calculation is carried out during the 3 months of the study, and within each particular case, It is carried out in the morning every day, from admission to discharge of the patient, up to 3 days.
Rate of patients diagnosed with delirium improving clinical severity
Every patient with a positive diagnostic and an active treatment. The objective is to avaluate the reduction of the symptoms with the Delirium Rating Scale-R-98 scale, in the morning, comparing control gropu and interventional group . The score is from 0 to 48 points, with a positive diagnosis with severity symptoms in scores greater than 12 points.
Time frame: Its calculation is carried out during the three months of the study, and within each particular case, in the morning every day, from the beginning of diagnosis to the improvement of the patient, up to 3 days.
Drug use rate for the treatment of delirium
Carried out with the recorded on the e-health program and the observation of the clinical history of each patient who have had a positive diagnosis of delirium in their hospitalitzation in the geriatric unit and has recorded the use of drugs, like number of a day and type of drug, for their treatment. Comparation control group and intervention group.
Time frame: Its calculation is carried out during the 3 months of the study, and within each particular case, in the end of the patient hospitalitzation, up to 3 days.
Plan to share: Yes — Data management plan ID 2872, University of Lleida. Only team researchers related to the project will have access to the data.
Supporting information: Study protocol
Time frame: 1 March 2026, start of patient recruitement, it is estimated that it will take approximately 3 months to collect the entire necessary sample. The total sample is estimated to be completed in June 2027.
Access criteria: IP Laia Fernández Parra. Doctoral thesis supervisors, Gloria Tor Nassarre and Aida Bonet Auge. Only data strictly necessary for the project will be accessed. The instructions of the ethics committee are followed.
Data sharing details ↗ · dmp.csuc.cat
Start is estimated for Apr 2026; primary completion for Jun 2027, 14 months later.
Of 219 non-industry interventional studies with no phase under Delirium, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 45. This study's planned 14 months is below that.
Counting every sponsor, half of 222 studies reached it within 26 months; a quarter within 12 and three quarters within 45.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in May 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universitat de Lleida